Targeted Treatment of Rare Childhood Leukemia
Juvenile myelomonocytic leukemia (JMML) is a rare but aggressive childhood leukemia. While hematopoietic stem cell transplantation is curative for some patients, approximately half of all patients see
University of California San Francisco
Give to UCSF
Displaying 91 - 120 of 478
-
-
I’m a Microplastics Researcher. Here’s How To Limit Their Dangers
Tracey Woodruff, PhD, MPH, offers insights on what her research on microplastics has led her to change how she and her family eats and what cleaning products she uses.
-
In Judo Move, Scientists Use Cancer’s Strength to Fight Against It
Cancer immunotherapy is hindered by the fact that engineered immune cells often get worn out and depleted before they've killed a tumor. A UCSF team has identified mutations that give cancerous lymphoma T-cells their superpower and transfer those genes into engineered, therapeutic immune cells.
-
Should People Test for Exposure to ‘Forever Chemicals’? CDC Offers Doctors New Guidance
-
Could Two Drugs Be Better Than One for Treating Prostate Cancer?
Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug.
-
Cancer Researcher Thomas Martin Receives $4.6 million CIRM Grant
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T
-
Dangerous Beauty
Cell biologist and engineer Matthew Kutys, PhD, and his team harness organoids – living tissues derived from patient tumors – to study how cancer spreads.
-
UCSF Health’s Eric J. Small, MD, Elected ASCO President for 2025-26 Term
Image Eric J. Small, MD, UCSF professor of Medicine and Urology Credit: UCSF The American Society of Clinical Oncology (ASCO) has elected Eric J.
-
All the Carcinogens We Cannot See
-
How to Improve Survival for Pediatric Leukemia Patients
Researchers at UCSF and UC Berkeley are investigating the impact of pre- and post-natal exposures to tobacco smoke on the survival rate of children with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
-
UCSF Health Experts Spotlight Advances at Hematology Conference
Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 65th Annual Meeting and Exposition. This year’s meeting will be held in San Diego from Dec. 8-12, 2023.
-
Over 30 UCSF Scientists Honored for Highest Impact in Their Fields
Thirty-two UCSF scientists are among the most influential individuals in their respective fields, according to the most recent analysis of research citations by the science and intellectual property company, Clarivate.
-
How to Decrease Advanced Breast Cancer Among Women of Color
UCSF researchers found that regular screening is not always sufficient to prevent an advanced breast cancer diagnosis.
-
The Path to Early Intervention: Build a Better Breast Cancer Predictor
Breast cancer was the second most commonly diagnosed cancer in women, after skin cancer – accounting for 31% of all new female cancer diagnoses in 2022. Yet, determining who is most at risk of breast
-
UCSF and UCLA Host First Annual PSMA PET Conference in January
University of California prostate cancer experts will share clinical insights at the first annual PSMA Conference, “PSMA PET and RLT: Present and Future.” The conference will take place online and in
-
Can Gene Expression Predict if a Brain Tumor Is Likely to Grow Back?
A gene expression test can accurately predict the best treatment for meningioma patients by measuring the aggressiveness of their tumors and adjusting treatment accordingly.
-
Younger Women Who Have Never Smoked Are at Increasing Risk of Lung Cancer, Research Shows
-
Breast Cancer Treatments Offer More Options Than Surgery
-
Do Combination Therapies Hold Hope for Prostate Cancer Patients?
A phase 1 trial shows promise in treating metastatic prostate cancer with a single priming dose of radioligand therapy and immunotherapy.
-
Breast Cancer Riddle: Best Ways to Screen and Treat
Laura Esserman discusses breast cancer risk factors, progress in the field and the importance of tailoring treatment for women with low-risk cancer while also identifying women at high risk of invasive cancer.
-
Breast Cancer Screening Guidelines Should Evolve With Science
-
The Growing Case for Doing Less: How Harmless Cancers Are Being Overdiagnosed in America
-
Study Finds Significant Chemical Exposures in Women With Cancer
Researchers have found that people who developed breast, ovary, skin and uterine cancers have significantly higher levels of endocrine-disrupting chemicals in their bodies.
-
Does Sugar Actually Feed Cancer?
-
The Cancer Breakthrough Boom
Engineered immune cells. Supercharged scans. Drug implants. Gene manipulators. Blood biopsies. Read how these breakthroughs are transforming cancer care.
-
Two UCSF Researchers Win Pew Awards for Biomedical Science
Two UCSF scientists – James Gardner, MD, PhD, and Rebeca de Pavia Fróes Rocha, PhD – have received Pew awards for their work in immunology as part of a program that supports promising early-career investigators.
-
Breast Density and BMI Both Play a Role in Breast Cancer Risk
Laws in many states require notifying women if they have dense breasts, a risk factor for breast cancer. But density shouldn’t be the only factor in determining whether supplemental screening is
-
UCSF Health Cancer Experts Featured at Premier Cancer Meeting
Oncology specialists from around the globe will gather for the American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest cancer therapies, technologies, research and education.
-
Personalizing Prostate Cancer Screening May Improve Accuracy of Detection
Taking into account genetic factors that can change PSA levels not associated with cancer, the screening accuracy can be improved.
-
Scientists Discover a Deadly Brain Cancer’s Hidden Weakness
UCSF scientists have found that brain cancer glioblastoma can cause cognitive decline by affecting neural connections, but the epilepsy drug gabapentin shows promise in blocking this activity, offering hope for new treatments.
